IL27 Receptor alpha antibody (AA 33-283)
Quick Overview for IL27 Receptor alpha antibody (AA 33-283) (ABIN7156877)
Target
See all IL27 Receptor alpha (IL27RA) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 33-283
-
Cross-Reactivity
- Human, Rat
-
Purification
- Antigen Affinity Purified
-
Immunogen
- Recombinant Human Interleukin-27 receptor subunit alpha protein (33-283AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- IL27 Receptor alpha (IL27RA) (Interleukin 27 Receptor, alpha (IL27RA))
-
Alternative Name
- IL27RA
-
Background
-
Background: Receptor for IL27. Requires IL6ST/gp130 to mediate signal transduction in response to IL27. This signaling system acts through STAT3 and STAT1. Involved in the regulation of Th1-type immune responses. Also appears to be involved in innate defense mechanisms.
Aliases: Class I cytokine receptor antibody, CRL1 antibody, Cytokine receptor-like 1 antibody, I27RA_HUMAN antibody, IL-27 receptor subunit alpha antibody, IL-27R subunit alpha antibody, IL-27R-alpha antibody, IL-27RA antibody, IL27R alpha antibody, IL27R antibody, Il27ra antibody, Interleukin 27 receptor alpha chain precursor antibody, Interleukin 27 receptor antibody, Interleukin-27 receptor subunit alpha antibody, Protein CRL1 antibody, T cell cytokine receptor type 1 antibody, TCCR antibody, Type 1 T cell cytokine receptor antibody, Type I T-cell cytokine receptor antibody, WSX-1 antibody, WSX1 antibody, ZcytoR1 antibody
-
UniProt
- Q6UWB1
-
Pathways
- Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response
Target
-